Archive for May, 2009
[Pharmacological treatment of dyslexia]
CONCLUSIONS: It is suggested that it would be wise to monitor the response in reading skills in children with dyslexia and attention deficit hyperactivity disorder (ADHD) who are being treated with stimulants. We also recommend taking into consideration the comorbidity between dyslexia and ADHD as an argument in favour of pharmacological intervention in patients with apparently mild symptoms of ADHD. In any case, today, pharmacological intervention cannot be expected to go beyond its having a complementary and synergic effect on traditional methods of treatment.
PMID: 19472157 [PubMed - in process] (Source: Revista de Neurologia)div id=medwormpbiMedWorm Message:/i/b Get the very latest Swine Flu news via the MedWorm ba href=http://www.m…
Effects of fluency, oral language, and executive function on reading comprehension performance.
Authors: Cutting LE, Materek A, Cole CA, Levine TM, Mahone EM
Reading disability (RD) typically consists of deficits in word reading accuracy and/or reading comprehension. While it is well known that word reading accuracy deficits lead to comprehension deficits (general reading disability, GRD), less is understood about neuropsychological profiles of children who exhibit adequate word reading accuracy but nevertheless develop specific reading comprehension deficits (S-RCD). Establishing the underlying neuropsychological processes associated with different RD types is essential for ultimately understanding core neurobiological bases of reading comprehension. To this end, the present study investigated isolated and contextual word fluency…
“Gene Silencing” May Improve Treatment Of A Deadly Complication Of Liver Disease
A technique that “silences,” or turns off, genes shows promise as a potential new treatment for liver fibrosis - the disease that leads to cirrhosis - scientists in Tennessee are reporting. Their study is scheduled for the June 1 issue of ACS’ Molecular Pharmaceutics, a bi-monthly journal. Cirrhosis is the 12th leading cause of death in the United States.Original post by Diabetes Notes
No commentsMental Health America’s Centennial Gala On June 11 To Honor Senators Edward Kennedy, Pete Domenici
Mental Health America, celebrating its 100th Anniversary as the founder of the organized mental health movement, will honor Senators Edward M. Kennedy and Pete Domenici for their legendary work in mental health at its Centennial Gala on Thursday, June 11, in Washington, D.C. Special guest speakers at the Gala include Mrs. Tipper Gore, Honorary Chair of Mental Health America’s Centennial Celebration, Former First Lady Mrs. Rosalynn Carter, award-winning actress Glenn Close, Dr.Original post by Diabetes Notes
No commentsStudent’s Design Helps Piece Together Parts Of The Alzheimer’s Puzzle
A Kingston University design student has turned his coursework into a budding business venture, launching a jigsaw puzzle ideal for people living with dementia. Ben Atkinson-Willes, 22, who is completing a degree in product and furniture design at Kingston University in South West London this year, was inspired to use his skills to create a specially-designed activity puzzle after his granddad was diagnosed with Alzheimer’s disease.Original post by Allergy News From Medical News Today
No commentsVideo Decision Support Tool For Advance Care Planning In Dementia: Randomised Controlled Trial, UK
Video images of advanced dementia can help patients choose the type of care they want in the future, finds a study published on bmj.com today. The images also led to more stable treatment preferences over time. Respecting patients’ preferences for treatment is a key component of high quality end of life care.Original post by Allergy News From Medical News Today
No commentsFDA Approves SBi’s S.T.A.R.(R) Total Ankle Replacement System
Small Bone Innovations, Inc. (SBi), a leading provider of innovation, products, technology and education for the small bone & joint segment of the orthopedics industry, announced that the U.S. Food and Drug Administration (FDA) has approved SBi’s Scandinavian Total Ankle Replacement (S.T.A.R.®) system to treat U.S. patients. S.T.A.R. has received pre-market approval (PMA) to replace a painful arthritic ankle joint due to osteoarthritis, post-traumatic arthritis or rheumatoid arthritis.Original post by Allergy News From Medical News Today
No commentsGene Network Sciences Announces Broad Cancer Collaboration With UCSF And Initial Results
Gene Network Sciences, Inc. (GNS) announced that it has entered into a research collaboration with the University of California San Francisco Cancer Center (UCSF) aimed at accelerating cancer research and drug development across several therapeutic areas. This collaboration will combine the clinical and research oncology expertise of UCSF with the computational expertise and supercomputer-driven REFS(TM) platform of GNS. Financial terms of the agreement were not disclosed.Original post by Allergy News From Medical News Today
No commentsGloucester Pharmaceuticals To Present New Data From Two Studies On Romidepsin At ASCO
Gloucester Pharmaceuticals announced that results from two studies of romidepsin, its novel, cyclic peptide, histone deacetylase inhibitor under investigation for the treatment of hematologic malignancies, will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Orlando, Florida on Saturday, May 30, 2009.Original post by Allergy News From Medical News Today
No commentsAgios Pharmaceuticals’ Focus Of Drug Research - Cancer Metabolism - Selected For Stand Up To Cancer Grant
Agios Pharmaceuticals today announced that Stand Up To Cancer (SU2C), a charitable initiative for new cancer treatments, has selected the Cancer Metabolism “dream team” led by Agios founder Dr. Craig Thompson and including Agios advisors Drs. Chi Dang and Joshua Rabinowitz. Cancer Metabolism is one of only five research areas chosen to share in $73.Original post by Allergy News From Medical News Today
No comments